Hikal Ltd.
HIKAL Share PricePharmaceuticals & Drugs
₹259.6
-2.5 (-1%)
As on September 8, 2025
Exchange Scrips: BSE524735NSEHIKALISININE475B01022
Market Cap ₹ 3,197 Cr
P/E Ratio 35.31
Dividend Yield 0.27 %
Performance
Market performance
Open262.6
High263.7
Volumes1,46,917
Prev259.6
Low258.55
As on2025-09-08
Historical performance
1 Year High464.75
3 Year High464.75
5 Year High742
1 Year Low245
3 Year Low245
5 Year Low143
Fundamentals
Company Valuation
Market Cap (₹Cr)
3,197
Face Value (₹)
2
P/E Ratio
35.31
Dividend Yield
0.27 %
Investment Returns
1 Year
-25.2%
3 Years
-23.7%
5 Years
62.7%
10 Years
281.8%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 263.73 | Bearish |
| 10-DMA | 259.65 | Bearish |
| 20-DMA | 260.87 | Bearish |
| 50-DMA | 306.07 | Bearish |
| 100-DMA | 346.96 | Bearish |
| 200-DMA | 364.85 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 18 | 22 | 22 | 22 | 22 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 18 | 22 | 22 | 22 | 22 |
| Public Investors | 71373 | 68885 | 71779 | 71890 | 70956 |
| Government | 1 | 1 | 1 | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 35.31.
- 3Y Stock Price CAGR of the stock is -8.7.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹3334 Million.
- The company generated revenue of ₹18598 Million in the previous financial year.
Hikal Ltd.
259.6-2.5 (-1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 689142.6
No. of Shares: 2655 (Approx)
Performance:-31.1%
P/L: ₹-310857.4
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent